Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Melanoma

Free Subscription Articles published in Cancer Retrieve available abstracts of 63 articles: HTML format Text format

Single Articles

January 2012
1. HWA C , Price LS, Belitskaya-Levy I, Ma MW, et al
   Single versus multiple primary melanomas: Old questions and new answers.
   Cancer. 2012 Jan 13. doi: 10.1002/cncr.27407.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
2. JAKOB JA , Bassett RL Jr, Ng CS, Curry JL, et al
   NRAS mutation status is an independent prognostic factor in metastatic melanoma.
   Cancer. 2011 Dec 16. doi: 10.1002/cncr.26724.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. SWETTER SM , Pollitt RA, Johnson TM, Brooks DR, et al
   Behavioral determinants of successful early melanoma detection: Role of self and physician skin examination.
   Cancer. 2011 Dec 16. doi: 10.1002/cncr.26707.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. POLLITT RA , Swetter SM, Johnson TM, Patil P, et al
   Examining the pathways linking lower socioeconomic status and advanced melanoma.
   Cancer. 2011 Dec 16. doi: 10.1002/cncr.26706.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
5. PRINTZ C
   Duke University researchers develop laser-based tool for melanoma.
   Cancer. 2011;117:4338-9.
   PubMed     Text format     Related articles   
   
   
   
   September 2011
6. JENSEN TO , Schmidt H, Moller HJ, Donskov F, et al
   Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.
   Cancer. 2011 Sep 22. doi: 10.1002/cncr.26511.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   July 2011
7. ERMAN AB , Collar RM, Griffith KA, Lowe L, et al
   Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.
   Cancer. 2011 Jul 19. doi: 10.1002/cncr.26288.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   June 2011
8. ZHANG Z , Chen G, Cheng Y, Martinka M, et al
   Prognostic significance of RUNX3 expression in human melanoma.
   Cancer. 2011;117:2719-27.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   May 2011
9. KLUGER HM , Dudek AZ, McCann C, Ritacco J, et al
   A phase 2 trial of dasatinib in advanced melanoma.
   Cancer. 2011;117:2202-8.
   PubMed     Text format     Related articles   
   
   
   
   
10. GADIOT J , Hooijkaas AI, Kaiser AD, van Tinteren H, et al
    Overall survival and PD-L1 expression in metastasized malignant melanoma.
    Cancer. 2011;117:2192-201.
    PubMed     Text format     Related articles   
    
    
    
    
11. MCLAUGHLIN JM , Fisher JL, Paskett ED
    Marital status and stage at diagnosis of cutaneous melanoma: Results from the Surveillance Epidemiology and End Results (SEER) program, 1973-2006.
    Cancer. 2011;117:1984-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
12. ZAKRZEWSKI J , Geraghty LN, Rose AE, Christos PJ, et al
    Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival.
    Cancer. 2011;117:1711-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. KOTTSCHADE LA , Suman VJ, Amatruda T 3rd, McWilliams RR, et al
    A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : A North Central Cancer Treatment Group Study, N057E(1).
    Cancer. 2011;117:1704-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. EIGENTLER TK , Figl A, Krex D, Mohr P, et al
    Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma.
    Cancer. 2011;117:1697-1703.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. OTHUS M , Moon J, Margolin K
    Melanoma's deadly march to the brain: By what route, and can it be stopped?
    Cancer. 2011;117:1560-3.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
16. KIRKWOOD JM , Gonzalez R, Reintgen D, Clingan PR, et al
    A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma.
    Cancer. 2011 Mar 31. doi: 10.1002/cncr.26068.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. SOSMAN JA , Moon J, Tuthill RJ, Warneke JA, et al
    A phase 2 trial of complete resection for stage IV melanoma: Results of Southwest Oncology Group Clinical Trial S9430.
    Cancer. 2011 Mar 31. doi: 10.1002/cncr.26111.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. OLLILA DW
    A phase 2 trial of complete resection for stage IV melanoma : Results of Southwest Oncology Group Clinical Trial S9430.
    Cancer. 2011 Mar 31. doi: 10.1002/cncr.26118.
    PubMed     Text format     Related articles   
    
    
    
    
19. KELLY P , Zagars GK, Cormier JN, Ross MI, et al
    Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: A 20-Year Experience.
    Cancer. 2011 Mar 28. doi: 10.1002/cncr.26088.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
20. MEIER A , Satzger I, Volker B, Kapp A, et al
    Reply to Assessment of capsular melanoma cell deposits in sentinel lymph nodes.
    Cancer. 2011 Jan 24. doi: 10.1002/cncr.25789.
    PubMed     Text format     Related articles   
    
    
    
    
21. BERTSCH HP , Kretschmer L
    Assessment of capsular melanoma cell deposits in sentinel lymph nodes.
    Cancer. 2011 Jan 24. doi: 10.1002/cncr.25785.
    PubMed     Text format     Related articles   
    
    
    
    December 2010
22. ZHANG Z , Chen G, Cheng Y, Martinka M, et al
    Prognostic significance of RUNX3 expression in human melanoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. MAUBEC E , Chaudru V, Mohamdi H, Grange F, et al
    Characteristics of the coexistence of melanoma and renal cell carcinoma.
    Cancer. 2010;116:5716-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. SNEYD MJ , Cox B
    Clinical and histologic factors associated with melanoma thickness in New Zealand Europeans, Maori, and Pacific peoples.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
25. KLUGER HM , Dudek AZ, McCann C, Ritacco J, et al
    A phase 2 trial of dasatinib in advanced melanoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. GADIOT J , Hooijkaas AI, Kaiser AD, van Tinteren H, et al
    Overall survival and PD-L1 expression in metastasized malignant melanoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. MCLAUGHLIN JM , Fisher JL, Paskett ED
    Marital status and stage at diagnosis of cutaneous melanoma: results from the surveillance epidemiology and end results (SEER) program, 1973-2006.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. OTHUS M , Moon J, Margolin K
    Melanoma's deadly march to the brain: by what route, and can it be stopped?
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
29. KOTTSCHADE LA , Suman VJ, Amatruda T 3rd, McWilliams RR, et al
    A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : a north central cancer treatment group study, N057E1.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. ZAKRZEWSKI J , Geraghty LN, Rose AE, Christos PJ, et al
    Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. EIGENTLER TK , Figl A, Krex D, Mohr P, et al
    Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
32. DAVIES MA , Liu P, McIntyre S, Kim KB, et al
    Prognostic factors for survival in melanoma patients with brain metastases.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
33. POLLITT RA , Clarke CA, Swetter SM, Peng DH, et al
    The expanding melanoma burden in California hispanics: importance of socioeconomic distribution, histologic subtype, and anatomic location.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
34. FLAHERTY KT , McArthur G
    BRAF, a target in melanoma: implications for solid tumor drug development.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. MEIER A , Satzger I, Volker B, Kapp A, et al
    Comparison of classification systems in melanoma sentinel lymph nodes-An analysis of 697 patients from a single center.
    Cancer. 2010;116:3178.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
36. NEYNS B , Tosoni A, Hwu WJ, Reardon DA, et al
    Dose-dense temozolomide regimens: antitumor activity, toxicity, and immunomodulatory effects.
    Cancer. 2010;116:2868-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. MOCELLIN S , Pasquali S
    Reply to False-positivity in the sentinel lymph nodes in melanoma and breast cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
38. GOGAS H , Kirkwood JM, Falk CS, Dafni U, et al
    Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferon.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. PARADELA S , Fonseca E, Pita-Fernandez S, Kantrow SM, et al
    Prognostic factors for melanoma in children and adolescents: a clinicopathologic, single-center study of 137 Patients.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. THOMAS JM
    False-positivity in the sentinel lymph nodes in melanoma and breast cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
41. WEIDE B , Derhovanessian E, Pflugfelder A, Eigentler TK, et al
    High response rate after intratumoral treatment with interleukin-2: results from a phase 2 study in 51 patients with metastasized melanoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. MURALI R , Shaw HM, Lai K, McCarthy SW, et al
    Prognostic factors in cutaneous desmoplastic melanoma: a study of 252 patients.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
43. HAINSWORTH JD , Infante JR, Spigel DR, Peyton JD, et al
    Bevacizumab and everolimus in the treatment of patients with metastatic melanoma: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. PRINTZ C
    Physicians optimistic about advances in lung cancer and melanoma treatment.
    Cancer. 2010;116:2287-8.
    PubMed     Text format     Related articles   
    
    
    
    April 2010
45. WEBER JS , Samlowski WE, Gonzalez R, Ribas A, et al
    A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. CROGHAN GA , Suman VJ, Maples WJ, Albertini M, et al
    A study of paclitaxel, carboplatin, and bortezomib in the treatment of metastatic malignant melanoma: a phase 2 Consortium study.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
47. KANETSKY PA , Panossian S, Elder DE, Guerry D, et al
    Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. PEREZ-GOMEZ B , Aragones N, Pollan M
    Divergent cancer pathways for early onset and late onset cutaneous malignant melanoma: a role for sex-site interaction.
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
49. ANDERSON WF , Tucker MA, Rosenberg PS
    Reply to Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma.
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
50. MOUGIAKAKOS D , Johansson CC, Trocme E, All-Ericsson C, et al
    Intratumoral forkhead box P3-positive regulatory T cells predict poor survival in cyclooxygenase-2-positive uveal melanoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. MORENO MA , Roberts DB, Kupferman ME, Demonte F, et al
    Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
52. XING Y , Chang GJ, Hu CY, Askew RL, et al
    Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. KASHANI-SABET M
    Tumor progression by immune evasion in melanoma: role of the programmed cell death-1/programmed cell death-1 ligand 1 interaction.
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
54. HINO R , Kabashima K, Kato Y, Yagi H, et al
    Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. KU GY , Yuan J, Page DB, Schroeder SE, et al
    Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
56. BHATT RS , Merchan J, Parker R, Wu HK, et al
    A phase 2 pilot trial of low-dose, continuous infusion, or "metronomic" paclitaxel and oral celecoxib in patients with metastatic melanoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. HERSEY P , Sosman J, O'Day S, Richards J, et al
    A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), +/- dacarbazine in patients with stage IV metastatic melanoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. MAYS MP , Martin RC, Burton A, Ginter B, et al
    Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. MESSINA JL , Sondak VK
    Refining the criteria for sentinel lymph node biopsy in patients with thinner melanoma: a roadmap for the future.
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
60. VYAS A , Avritscher R, Ensor J, Ross M, et al
    Isolated limb infusion with cytotoxic agents: a simplified approach for venous access.
    Cancer. 2010;116:459-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. PASQUALI S , Mocellin S, Campana LG, Bonandini E, et al
    Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases : personal Experience and Literature Meta-Analysis.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. BYRD DR
    The persistent anchor of lymph node removal in patients with melanoma.
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
63. URSO C
    The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution.
    Cancer. 2010;116:258.
    PubMed     Text format     Related articles   
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: